Metabolic syndrome is not associated with markers of subclinical atherosclerosis, serum adiponectin and endogenous androgen concentrations in Japanese men with Type 2 diabetes

Diabetic Medicine

Volumn 24, Issue 8, 2007, Pages 864-871

  Fukui, M ^a   Ose, H ^a   Kitagawa, Y ^b   Kamiuchi, K ^b   Nakayama, I ^b   Ohta, M ^c   Obayashi, H ^d   Yamasaki, M ^a   Hasegawa, G ^a   Yoshikawa, T ^a   Nakamura, N ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b WEST JAPAN RAILWAY COMPANY   (Japan)

^c KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

^d Institute of Bio Response Informatics   (Japan)

Author keywords

Adipocytokine; Androgen; Atherosclerosis; Metabolic syndrome; Type 2 diabetes

Indexed keywords

ADIPONECTIN; ANDROGEN; PRASTERONE SULFATE; TESTOSTERONE;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; ECHOGRAPHY; HUMAN; JAPANESE; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PULSE WAVE;

ADIPONECTIN; ADULT; AGED; ANDROGENS; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; HUMANS; JAPAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; RISK FACTORS;

EID: 34447647279     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2007.02213.x     Document Type: Article

References (37)

1. Alberti KG, Zimmet P, Shaw J for the IDF Epidemiology Task Force Consensus Group. The metabolic syndrome - a new worldwide definition. Lancet 2005 366 : 1059 1062.
2. Iglseder B, Cip P, Malaimare L, Ladurner G, Paulweber B. The metabolic syndrome is a stronger risk factor for early carotid atherosclerosis in women than in men. Stroke 2005 36 : 1212 1217.
3. Nakanishi N, Suzuki K, Tatara K. Clustered features of the metabolic syndrome and the risk for increased aortic pulse wave velocity in middle-aged Japanase men. Angiology 2003 54 : 551 559.
4. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004 89 : 2548 2556.
5. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 2004 24 : 29 33.
6. Muller M, Grobbee DE, den Tonkelaar I, Lamberts SWJ, van der Schouw YT. Endogenous sex hormones and metabolic syndrome in aging men. J Clin Endocrinol Metab 2005 90 : 2618 2623.
7. Seidell JC, Bjorntorp P, Sjostrom L, Kvist H, Sannerstedt R. Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels. Metabolism 1990 39 : 897 901.
8. Laaksonen DE, Niskanen L, Punnonen K, Nyyssonen K, Tuomainen TP, Salonen R et al. Sex hormone, inflammation and the metabolic syndrome: a population-based study. Eur J Endocrinol 2003 149 : 601 608.
9. De Pergola G, Pannacciulli N, Ciccone M, Tartagni M, Rizzon P, Giorgino R. Free testosterone plasma levels are negatively associated with the intima-media thickness of the common carotid artery in overweight and obese glucose-tolerant young adult men. Int J Obes Relat Metab Disord 2003 27 : 803 807.
10. Expert Panel on Detection, Evaluation Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). J Am Med Assoc 2001 285 : 2486 2497.
11. The Expert Committee on the Diagnosis Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2002 25 : S5 S20.
12. Hasegawa G, Ohta M, Ichida Y, Obayashi H, Shigeta M, Yamasaki M et al. Increased serum resistin levels in patients with type 2 diabetes are not linked with markers of insulin resistance and adiposity. Acta Diabetol 2005 42 : 104 109.
13. Fukui M, Kitagawa Y, Nakamura N, Kadono M, Mogami S, Hirata C et al. Association between serum testosterone concentration and carotid atherosclerosis in men with type 2 diabetes. Diabetes Care 2003 26 : 1869 1873.
14. Fukui M, Kitagawa Y, Nakamura N, Kadono M, Hasegawa G, Yoshikawa T. Association between urinary albumin excretion and serum dehydroepiandrosterone sulfate concentration in male patients with type 2 diabetes: a possible link between urinary albumin excretion and cardiovascular disease. Diabetes Care 2004 27 : 2893 2897.
15. Tan CE, Ma S, Wai D, Chew SK, Tai ES. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care 2004 27 : 1182 1186.
16. Jorgensen ME, Borch-Johnsen K. The metabolic syndrome. Is one global definition possible? Diabet Med 2004 21 : 1064 1065.
17. Examination Committee of Criteria for 'Obesity Disease' in Japan, Japan Society for the Study of Obesity. New criteria for 'obesity disease' in Japan. Circ J 2002 66 : 987 992.
18. Fukui M, Kitagawa Y, Nakamura N, Mogami S, Ohnishi M, Hirata C et al. Augmentation of central arterial pressure as a marker of atherosclerosis in patients with type 2 diabetes. Diabetes Res Clin Pract 2003 59 : 153 161.
19. Yamashina A, Tomiyama H, Takeda K, Tsuda H, Arai T, Hirose K et al. Validity, reproducibility, and clinical significance of non-invasive brachial-ankle pulse wave velocity measurement. Hypertens Res 2002 25 : 359 364.
20. Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V et al. The metabolic syndrome and chronic kidney disease in US adults. Ann Intern Med 2004 140 : 167 174.
21. Mykkanen L, Zaccaro DJ, O'Leary DH, Howard G, Robbins DC, Haffner SM. Microalbuminuria and carotid artery intima-media thickness in non-diabetic and NIDDM subjects: the Insulin Resistance Atherosclerosis Study (IRAS). Stroke 1997 28 : 1710 1716.
22. Dinneen SF, Gerstein HC. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus: a systematic overview of the literature. Arch Intern Med 1997 157 : 1413 1418.
23. Mohan V, Deepa R, Pradeepa R, Vimaleswaran KS, Mohan A, Velmurugan K et al. Association of low adiponectin levels with the metabolic syndrome - the Chennai Urban Rural Epidemiology Study (CURES-4). Metabolism 2005 54 : 476 481.
24. Ryo M, Nakamura T, Kihara S, Kumada M, Shibazaki S, Takahashi M et al. Adiponectin as a biomarker of the metabolic syndrome. Circ J 2004 68 : 975 981.
25. Choi KM, Lee J, Lee KW, Seo JA, Oh JH, Kim SG et al. Serum adiponectin concentrations predict the developments of type 2 diabetes and the metabolic syndrome in elderly Koreans. Clin Endocrinol 2004 61 : 75 80.
26. Katzmarzyk PT, Janssen I, Ross R, Church TS, Blair SN. The importance of waist circumference in the definition of metabolic syndrome: prospective analyses of mortality in men. Diabetes Care 2006 29 : 404 409.
27. Laaksonen DE, Niskanen L, Punnonen K, Nyyssonen K, Tuomainen TP, Valkonen VP et al. Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care 2004 27 : 1036 1041.
28. Laaksonen DE, Niskanen L, Punnonen K, Nyyssonen K, Tuomainen TP, Valkonen VP et al. The metabolic syndrome and smoking in relation to hypogonadism in middle-aged men: a prospective cohort study. J Clin Endocrinol Metab 2005 90 : 712 719.
29. Smith JC, Bennett S, Evans LM, Kynaston HG, Parmar M, Mason MD et al. The effects of induced hypogonadism on arterial stiffness, body composition, and metabolic parameters in males with prostate cancer. J Clin Endocrinol Metab 2001 86 : 4261 4267.
30. Marin P, Holmang S, Jonsson L, Sjostrom L, Kvist H, Holm G et al. The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. Int J Obes Relat Metab Disord 1992 16 : 991 997.
31. Haffner SM, Karhapaa P, Mykkanen L, Laakso M. Insulin resistance, body fat distribution and sex hormones in men. Diabetes 1994 43 : 12 19.
32. Andersson B, Marin P, Lissner L, Vermeulen A, Bjorntorp P. Testosterone concentrations in women and men with NIDDM. Diabetes Care 1994 17 : 405 411.
33. Guzder RN, Gatling W, Mullee MA, Byrne CD. Impact of metabolic syndrome criteria on cardiovascular disease risk in people with newly diagnosed type 2 diabetes. Diabetologia 2005 49 : 49 55.
34. Sone H, Tanaka S, Ishibashi S, Yamasaki Y, Oikawa S, Ito H et al. for the Japan Diabetes Complications Study (JDCS) Group. The new worldwide definition of metabolic syndrome is not a better diagnostic predictor of cardiovascular disease in Japanese diabetic patients than the existing definitions: additional analysis from the Japan Diabetes Complications Study. Diabetes Care 2006 29 : 145 147.
35. Rathmann W, Haastert B, Icks A, Giani G, Holle R, Koenig W et al. Prevalence of the metabolic syndrome in the elderly population according to IDF, WHO and NCEP definitions and associations with C-reactive protein: the KORA Survey 2000. Diabetes Care 2006 29 : 461.
36. Lu B, Yang Y, Song X, Dong X, Zhang Z, Zhou L et al. An evaluation of the International Diabetes Federation definition of metabolic syndrome in Chinese patients older than 30 years and diagnosed with type 2 diabetes mellitus. Metabolism 2006 55 : 1088 1096.
37. Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the study of diabetes. Diabetologia 2005 48 : 1684 1699.